1. Home
  2. CBC vs RGEN Comparison

CBC vs RGEN Comparison

Compare CBC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBC

Central Bancompany Inc.

N/A

Current Price

$29.48

Market Cap

6.4B

Sector

N/A

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$145.13

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBC
RGEN
Founded
1902
1981
Country
United States
United States
Employees
3036
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
CBC
RGEN
Price
$29.48
$145.13
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$28.67
$167.67
AVG Volume (30 Days)
792.5K
971.4K
Earning Date
04-28-2026
05-05-2026
Dividend Yield
2.21%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
$12.15
$14.30
Revenue Next Year
$6.34
$14.52
P/E Ratio
$14.38
$968.40
Revenue Growth
N/A
35.10
52 Week Low
$22.50
$100.99
52 Week High
$29.92
$175.77

Technical Indicators

Market Signals
Indicator
CBC
RGEN
Relative Strength Index (RSI) 62.68 70.07
Support Level $26.86 $141.44
Resistance Level N/A $172.45
Average True Range (ATR) 0.85 6.22
MACD 0.06 1.41
Stochastic Oscillator 85.11 85.92

Price Performance

Historical Comparison
CBC
RGEN

About CBC Central Bancompany Inc.

Central Bancompany Inc is a bank holding company that provides a broad range of retail, corporate, mortgage banking, wealth management, and trust products and services to individuals and businesses. Its operating segments include Consumer, Commercial, and Wealth Management. The company generates the majority of its revenue from the Commercial segment, which provides full-service relationship banking solutions to businesses, agencies, and community organizations, including commercial, small business, and government clients. The segment also offers business payment solutions such as treasury management services, merchant services, and commercial bank card products.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: